Join the club for FREE to access the whole archive and other member benefits.

Elevian

Young blood medicine maker for body rejuvenation.

Elevian develops regenerative medicines that target root-cause aging mechanisms. We are a spin out from Harvard, led by a team of serial entrepreneurs and Harvard scientists.

Elevian’s founders have identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms. One well published example, GDF11, reduces age-related cardiac hypertrophy, accelerates skeletal muscle repair, and improves cognitive function in aged mammals. We are developing biotherapeutics that regulate these blood factors.

Visit website: https://www.elevian.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Elevian Blog Posts

Ambrosia Plasma relaunches - announces improvement in key ageing biomarkers
03-Feb-2020 The Club interviews Jesse Karmazin, CEO, to find out more about the trial, the FDA warning, and the relaunch

People at Elevian

Advocate

Investor, entrepreneurial community builder, advocate

Company Representative

Co-Founder and CEO at Elevian

Elevian News

Elevian raises $15M in preclinical work towards clinical antiaging

FierceBiotech - 24-Nov-2020

rGDF11 in clinic targets multiple age related disease therapies

Read more...